Organisation for Oncology and Translational Research   Report issue

Academic/Hospital Phase 2
Founded: Hong Kong (2002)

Organization Overview

First Clinical Trial
2006
NCT00135018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 5